The current PE ratio for Prestige Consumer Healthcare stock as of Oct 22, 2024 is 17.37. This is calculated based on the current EPS of $4.13 and the stock price of $71.74 per share.
The average historical PE ratio of Prestige Consumer Healthcare for the last ten years is 19.74. The current PE ratio of 17.37 is 12% below the historical average. Over the past ten years, PBH's PE ratio was at its highest in the Jun 2016 quarter at 42.95, when the stock price was $55.4 and the EPS was $1.29. The lowest value was in the Mar 2018 quarter, when it reached 5.27 with a price of $33.72 and an EPS of $6.4.
Maximum annual increase: 50.12% in 2017
Maximum annual decrease: -87.57% in 2018
Year | PE ratio | Change |
---|---|---|
2024 | 17.24 | N/A |
2023 | N/A | N/A |
2022 | 12.94 | -3.72% |
2021 | 13.44 | 2.99% |
2020 | 13.05 | N/A |
2019 | N/A | N/A |
2018 | 5.27 | -87.57% |
2017 | 42.41 | 50.12% |
2016 | 28.25 | -1.19% |
2015 | 28.59 | 47.9% |
PBH's current P/E ratio is above the 3 and 5-year historical averages, but it is below the 10-year average.
PBH's PE ratio is lower than its peer stocks PG and ABT, but it is greater than JNJ's and NVS's. Prestige Consumer Healthcare's current PE ratio of 17.37 is below the average of its peers, which is 28.47.
Stock name | PE ratio | Market cap |
---|---|---|
CVS CVS HEALTH Corp | 10.07 | $71.43B |
JNJ Johnson & Johnson | 10.89 | $399.34B |
NVS Novartis AG | 14.44 | $232.75B |
PBH Prestige Consumer Healthcare Inc | 17.47 | $3.58B |
PG PROCTER & GAMBLE Co | 28.55 | $399.4B |
ABT Abbott Laboratories | 36.8 | $203.59B |
CLX Clorox Co | 70.37 | $19.7B |
PFE Pfizer Inc | N/A | $163.54B |
The price to earnings ratio for PBH stock is 17.37 as of Oct 22, 2024.
The average PE ratio for PBH stock over the past 3 years is 14.91.
The average PE ratio for PBH stock over the past 5 years is 13.95.
In the last ten years, the Jun 2016 quarter recorded the highest quarterly PE ratio at 42.95.
The current price to earnings ratio of PBH is 12% lower than the 10-year historical average.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Oct 22, 2024), Prestige Consumer Healthcare's stock price is $71.74. The earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $4.13. Therefore, Prestige Consumer Healthcare's P/E ratio for today is 17.37. PE RATIO(17.37) = STOCK PRICE($71.74) / TTM EPS($4.13)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.